11.07.2015 Views

FINAL PROGRAM - American Society of Gene & Cell Therapy

FINAL PROGRAM - American Society of Gene & Cell Therapy

FINAL PROGRAM - American Society of Gene & Cell Therapy

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

114<strong>American</strong> <strong>Society</strong> <strong>of</strong> <strong>Gene</strong> & <strong>Cell</strong> <strong>Therapy</strong>Abstract DirectoryFriday, May 21 stFriday, May 21, 2010Poster Session II— continued6:30 PM - 8:30 PMRoom: Exhibit Hall C & B-SouthOphthalmic Disorders and Technological Advances450Characterization <strong>of</strong> 12 AAV Vectors for Intravascular Delivery ToTarget CNS and Detarget Non-CNS Tissues by miRNA Regulation:Implications in Treatment <strong>of</strong> Canavan DiseaseHongwei Zhang, Bin Yang, Jun Xie, Qing Xie, Qin Su, Ran He, Miguel Sena-Esteves,Zuoshang Xu, Guangping Gao.451Efficient Expression <strong>of</strong> Smn from Integration-Deficient LentiviralVectorsSherif O. Ahmed, Hugo Peluffo, Edmund Foster, Natalia Lago, Lawrence Moon, ThomasHutson, Ping Yip, Klaus Wanisch, Stephen B. McMahon, Rafael J. Yáñez-Muñoz.452Efficacy <strong>of</strong> an Adenovirus Vector/Cocaine Conjugate-Based Anti-Cocaine Vaccine in Shielding the Brain from Systemically AdministeredCocaineMartin J. Hicks, Bishnu P. De, Jonathan B. Rosenberg, Jesse T. Davidson, Amira Y.Moreno, Kim D. Janda, Neil R. Hackett, Stephen M. Kaminsky, Stefan Worgall, RonaldG. Crystal.453<strong>Gene</strong>tically Engineered Suppressor <strong>Cell</strong>s Target CNS and InhibitActivated Effector T-<strong>Cell</strong>sMoa Fransson, Elena Piras, Hao Wang, Ida Rasmusson, Katarina LeBlanc, Eva Brittebo,Angelica S. I. Loskog.Musculo-skeletal <strong>Gene</strong> & <strong>Cell</strong> <strong>Therapy</strong> II454First <strong>Gene</strong>ration AAVmicroutrophin Vector Infused into the IsolatedPelvic Limb <strong>of</strong> a Canine Model for Duchenne Muscular DystrophyMihail Petrov, Marilyn Mitchell, Alock Malik, Andy Mead, Frederick Balzer, Leonard Su,Jacqueline Farag, Benjamin Kozyak, Kapil Gopal, Charles Bridges, Janet Bogan, MartinChilders, Joe Kornegay, Hansell Stedman.455Characterization <strong>of</strong> A20 as an Inhibitor <strong>of</strong> NF-kB Activation inDystrophic MiceRakshita Charan, Paula R. Clemens.456Plasticity <strong>of</strong> Skeletal Muscle <strong>Cell</strong>s during Muscle Injury and Repair –A Dedifferentiation StudyXiaodong Mu, Hairong Peng, Johnny Huard, Yong Li.457Increased Muscle Regeneration in Hindlimb and Diaphragm <strong>of</strong> mdxMice Treated with AAV9 Mini-Dystrophin and Octalysine-NEMOBinding Domain PeptideDaniel P. Reay, Geno Raggi, Bing Wang, Xiao Xiao, Paul D. Robbins, Paula R. Clemens.458External, Non-Invasive Monitoring <strong>of</strong> Progressive CardiorespiratoryDysfunction in a Canine Model <strong>of</strong> DMDAndrew Mead, Alock Malik, Mihail Petrov, Martin Childers, Janet Bogan, JosephKornegay, Hansell Stedman.459The Polyproline Site in Hinge 2 Influences the Functional Capacity <strong>of</strong>Truncated DystrophinsGlen B. Banks, Luke M. Judge, James M. Allen, Jeffrey S. Chamberlain.460Combining <strong>Gene</strong> and Stem <strong>Cell</strong> <strong>Therapy</strong> in the Treatment <strong>of</strong>DysferlinophatiesDaniele Parolini, Claire Navarro, Andrea Farini, Mirella Meregalli, Marzia Belicchi, PaolaRazini, M. Krahn, Louis Garcia, Nicolas Lévis, Yvan Torrente.461Deletion <strong>of</strong> Functional Domains <strong>of</strong> Dp116 Leads to AlteredSarcolemmal Expression and Subcellular Localization When Expressedin Skeletal MuscleAndrea L. Arnett, Guy L. Odom, Kristy Boyle, Eric Finn, Jeffrey S. Chamberlain.462A New Therapeutic Approach for Duchenne Muscular Dystrophy:Restoration <strong>of</strong> the Dystrophin Reading Frame with a MeganucleaseJacques P. Tremblay, Pierre Chapdelaine, Christophe Pichavant, Joel Rousseau, FrédéricPâques.463Regulatory Cassettes Derived from the Slow Troponin I <strong>Gene</strong>Confer High-Level Expression in Skeletal Muscle after <strong>Gene</strong> TransferMediated by Helper-Dependent Adenovirus and Recombinant AAVRénald Gilbert, Mehdi Bendjelloul, Yué Zeng, Claude Guérin, Nancy Larochelle, GeorgeKarpati, Bernard Massie, Josephine Nalbantoglu.464<strong>Cell</strong> <strong>Therapy</strong> <strong>of</strong> Muscular Dystrophy with Engineered Cd133+ <strong>Cell</strong>sAndrea Farini, Mirella Meregalli, Daniele Parolini, Marzia Belicchi, Simona Maciotta,Paola Razini, Joao da Silva Bizario, Luis Garcia, Nereo Bresolin, Yvan Torrente.465Improved Regenerative Capacity <strong>of</strong> Adult Stem <strong>Cell</strong>s Isolated fromInjured Skeletal Muscle <strong>of</strong> MouseXiaodong Mu, Ian Bellayr, Haiying Pan, Yong Li.466Sarcolemmal nNOS Anchoring Reveals a Functional Differencebetween Dystrophin and UtrophinYongping Yue, Dejia Li, Luke Judge, Akshay Bareja, Yi Lai, Kay E. Davies, Jeffrey S.Chamberlain, Dongsheng Duan.EXHIBITOR PROSPECTUSfinal program

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!